Product
mRNA-1273.529
3 clinical trials
1 indication
Indication
COVID-19Clinical trial
A Phase 2/3 Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 VariantsStatus: Completed, Estimated PCD: 2023-11-17
Clinical trial
A Phase 2/3, Randomized, Observer-blind, Active-controlled, Multicenter Study to Evaluate the Immunogenicity and Safety of Omicron Variant Vaccines in Comparison With mRNA-1273 (Prototype) Booster VaccineStatus: Completed, Estimated PCD: 2023-06-23
Clinical trial
Phase 2 Clinical Trial to Optimize Immune Coverage of SARS-CoV-2 Existing and Emerging VariantsStatus: Completed, Estimated PCD: 2023-11-22